Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.810
+0.050 (2.84%)
May 12, 2025, 4:00 PM - Market closed

Phio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
93251416
Upgrade
Market Cap Growth
67.92%67.92%-63.48%-62.43%-12.96%146.99%
Upgrade
Enterprise Value
3-2-6-9-13-1
Upgrade
Last Close Price
1.811.806.8440.18108.00290.52
Upgrade
Forward PE
0.420.13-0.372.19-
Upgrade
PB Ratio
0.660.660.240.470.621.20
Upgrade
P/TBV Ratio
1.830.660.240.470.621.20
Upgrade
Debt / Equity Ratio
--0.010.020.010.05
Upgrade
Quick Ratio
5.305.305.206.087.846.49
Upgrade
Current Ratio
5.655.655.716.428.066.91
Upgrade
Return on Equity (ROE)
-114.83%-114.83%-116.60%-70.06%-76.04%-93.73%
Upgrade
Return on Assets (ROA)
-61.14%-61.14%-60.30%-37.72%-41.28%-46.22%
Upgrade
Return on Capital (ROIC)
-73.94%-73.94%-71.23%-43.11%-47.06%-55.16%
Upgrade
Earnings Yield
-82.67%-229.29%-582.98%-225.78%-98.17%-56.55%
Upgrade
FCF Yield
-82.25%-228.10%-579.10%-240.93%-87.99%-56.73%
Upgrade
Buyback Yield / Dilution
-240.15%-240.15%-83.32%-6.30%-179.70%-
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q